cilomilast has been researched along with Pulmonary Disease, Chronic Obstructive in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 28 (80.00) | 29.6817 |
2010's | 6 (17.14) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Jabaris, SS; Kodimuthali, A; Pal, M | 1 |
Huang, L; Jiang, HL; Lai, KF; Li, XS; Luo, ZH; Shan, WJ; Zhou, Q | 1 |
Fortescue, R; Janjua, S; Poole, P | 1 |
Chong, J; Leung, B; Poole, P | 2 |
Fang, Q; Liu, X; Ma, Y; Michalski, J; Rennard, SI; Wang, J | 1 |
Agusti, A | 1 |
Barnhart, F; Canonica, WG; Knobil, K; Locantore, N; Morris, A; Rabe, KF; Rennard, S; Schachter, N; Zhu, Y | 1 |
Tatlicioğlu, T | 1 |
Black, PN; Chong, J; Leung, B; Poole, P | 1 |
Dougall, IG; Ratcliffe, MJ | 1 |
Giembycz, MA | 3 |
Baan, R; Gauw, SA; Grootendorst, DC; Kelly, J; Murdoch, RD; Rabe, KF; Sterk, PJ | 1 |
Amit, O; Barnes, NC; Brightling, CE; Compton, C; Edelson, J; Gamble, E; Grootendorst, DC; Hansel, TT; Jeffery, PK; Kroegel, C; Majumdar, S; Matin, D; Morell, F; Parker, D; Pavord, ID; Qiu, Y; Rabe, KF; Rennard, SI; Tat, T; Troy, S; Vignola, AM; Zhu, J | 1 |
Bellia, V; Bousquet, J; Chiappara, G; Chimenti, L; Costanzo, G; Di Giorgi, R; Mirabella, F; Profita, M; Riccobono, L; Vignola, AM | 1 |
Devillier, P | 1 |
Kerstjens, HA; Timens, W | 1 |
Dai, YR; Xia, XD; Xu, ZJ | 1 |
Vignola, AM | 1 |
Belleguic, C; Bertrand, C; Brinchault, G; Depincé, A; Lagente, V; Leportier-Comoy, C; Martin-Chouly, CA; Ouagued, M; Pruniaux, MP | 1 |
Hanania, NA; Soto, FJ | 1 |
Brown, WM | 1 |
Cortijo, J; Morcillo, EJ; Sanz, MJ | 1 |
Celli, B | 1 |
Amit, O; Rennard, SI; Rickard, K; Schachter, N; Strek, M | 1 |
Fan Chung, K | 1 |
Daley-Yates, P; Down, G; Lim, S; Siederer, S | 1 |
Artola, M; Berthelier, C; Bertrand, CP; Eichholtz, T; Lagente, V; Leclerc, O; Planquois, JM; Schmidlin, F | 1 |
Bitter-Suermann, S; Kanniess, F; Magnussen, H; Watz, H | 1 |
Schachter, EN | 1 |
Ismail, MS; Martina, SD; Vesta, KS | 1 |
Cui, X; Wang, D | 1 |
Fitzgerald, M; Sturton, G | 1 |
23 review(s) available for cilomilast and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2008 |
Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aminopyridines; Benzamides; Cyclohexanecarboxylic Acids; Cyclopropanes; Diarrhea; Disease Progression; Forced Expiratory Volume; Humans; Middle Aged; Nitriles; Peak Expiratory Flow Rate; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Thiazoles; Vital Capacity | 2020 |
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aminopyridines; Benzamides; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Progression; Forced Expiratory Volume; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic | 2017 |
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aminopyridines; Benzamides; Cyclohexanecarboxylic Acids; Cyclopropanes; Forced Expiratory Volume; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic | 2013 |
The efficacy and safety of cilomilast in COPD.
Topics: Bronchodilator Agents; Carboxylic Acids; Clinical Trials, Phase III as Topic; Cyclohexanecarboxylic Acids; Double-Blind Method; Humans; Multicenter Studies as Topic; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic | 2008 |
[Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Benzamides; Carboxylic Acids; Cyclic AMP; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2008 |
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aminopyridines; Benzamides; Cyclohexanecarboxylic Acids; Cyclopropanes; Forced Expiratory Volume; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic | 2011 |
Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far.
Topics: Aminopyridines; Asthma; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclohexanecarboxylic Acids; Cyclopropanes; Drug Interactions; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2002 |
[Physiopathology of COPD: choosing the right therapeutic targets].
Topics: Adrenal Cortex Hormones; Aged; Albuterol; Animals; Bacterial Infections; Bronchodilator Agents; Carboxylic Acids; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Therapy, Combination; Humans; Inflammation; Mucociliary Clearance; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Randomized Controlled Trials as Topic; Rats; Rolipram; Salmeterol Xinafoate; Smoking; Theophylline; Time Factors | 2003 |
Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Anti-Inflammatory Agents; Bronchodilator Agents; Carboxylic Acids; CD8-Positive T-Lymphocytes; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Humans; Inflammation; Leukocyte Count; Neutrophils; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2003 |
[Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Asthma; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Lung Diseases; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridines | 2004 |
PDE4 inhibitors in COPD--a more selective approach to treatment.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Nitriles; Phosphodiesterase Inhibitors; Pneumonia; Pulmonary Disease, Chronic Obstructive; Rolipram; Theophylline; Treatment Outcome | 2004 |
Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amides; Aminopyridines; Benzamides; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Indoles; Inflammation; Lung; Nitriles; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Disease, Chronic Obstructive | 2005 |
Cilomilast GlaxoSmithKline.
Topics: Animals; Carboxylic Acids; Cyclohexanecarboxylic Acids; Drug Industry; Humans; Meta-Analysis as Topic; Nitriles; Pulmonary Disease, Chronic Obstructive | 2005 |
PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Carboxylic Acids; Cell Adhesion Molecules; Cell Movement; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2005 |
Phosphodiesterase inhibitors in airways disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Aminopyridines; Animals; Anti-Inflammatory Agents; Asthma; Benzamides; Carboxylic Acids; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Isoenzymes; Nitriles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Disease, Chronic Obstructive | 2006 |
Clinical pharmacology of Cilomilast.
Topics: Animals; Carboxylic Acids; Cyclohexanecarboxylic Acids; Drug Interactions; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2006 |
[Pharmacological treatment of COPD and future of anti-inflammatory therapy].
Topics: Acetylcysteine; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Bronchodilator Agents; Carboxylic Acids; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Dyspnea; Expectorants; Forced Expiratory Volume; Forecasting; Humans; Inflammation; Infliximab; Lung; Macrolides; Nitriles; Phosphodiesterase Inhibitors; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Research; Respiratory Function Tests; Simvastatin; Smoking Cessation; Tetracycline; Theophylline; Tumor Necrosis Factor-alpha | 2006 |
Cilomilast.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bronchodilator Agents; Carboxylic Acids; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Interactions; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic | 2006 |
An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Aged, 80 and over; Carboxylic Acids; Clinical Trials, Phase III as Topic; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Female; Humans; Male; Middle Aged; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Research Design; Respiratory Function Tests; Treatment Outcome | 2006 |
Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2006 |
Evaluation of PDE4 inhibition for COPD.
Topics: Aminopyridines; Benzamides; Calcium Channel Blockers; Carboxylic Acids; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2006 |
Phosphodiesterase 4 inhibitors for the treatment of COPD.
Topics: Aminopyridines; Animals; Benzamides; Bronchodilator Agents; Carboxylic Acids; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2002 |
4 trial(s) available for cilomilast and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Albuterol; Analysis of Variance; Area Under Curve; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ipratropium; Male; Maximal Expiratory Flow Rate; Middle Aged; Nitriles; Pulmonary Disease, Chronic Obstructive | 2003 |
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Bronchodilator Agents; Carboxylic Acids; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Interleukin-8; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Sputum; Treatment Outcome | 2003 |
The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Azepines; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dexamethasone; Dose-Response Relationship, Drug; Female; France; Humans; Male; Middle Aged; Niacinamide; Nitriles; Phosphodiesterase Inhibitors; Polysaccharides, Bacterial; Pulmonary Disease, Chronic Obstructive; Rolipram; Tumor Necrosis Factor-alpha | 2005 |
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Aged, 80 and over; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Treatment Outcome | 2006 |
8 other study(ies) available for cilomilast and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Drug Design; Guinea Pigs; Inhibitory Concentration 50; Molecular Structure; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Trachea | 2012 |
PGE 2 desensitizes β -agonist effect on human lung fibroblast-mediated collagen gel contraction through upregulating PDE4.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Fibroblasts; Gels; Gene Expression Regulation; Humans; Indomethacin; Lung; Nitriles; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Up-Regulation | 2013 |
The efficacy and safety of cilomilast in COPD. Forward.
Topics: Bronchodilator Agents; Carboxylic Acids; Cyclohexanecarboxylic Acids; Humans; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2008 |
Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages.
Topics: Anti-Inflammatory Agents; Budesonide; Cells, Cultured; Cyclohexanecarboxylic Acids; Female; Humans; Interleukin-6; Lipopolysaccharides; Macrophages, Alveolar; Male; Middle Aged; Naphthalenes; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase 4 Inhibitors; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyrazoles; Tumor Necrosis Factor-alpha | 2012 |
Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
Topics: Adult; Aged; Bronchodilator Agents; Carboxylic Acids; Cell Count; Cells, Cultured; Chemotaxis, Leukocyte; Cyclohexanecarboxylic Acids; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-8; Male; Middle Aged; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Sputum; Tumor Necrosis Factor-alpha | 2003 |
COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Forced Expiratory Volume; Humans; Inflammation; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2006 |
Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bronchoalveolar Lavage Fluid; Carboxylic Acids; Chromosome Deletion; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neutrophils; Nitriles; Pneumonia; Pulmonary Disease, Chronic Obstructive; Smoking | 2006 |
Cilomilast: a breath of relief?
Topics: Bronchodilator Agents; Carboxylic Acids; Clinical Trials, Phase III as Topic; Cyclohexanecarboxylic Acids; Humans; Lung; Multicenter Studies as Topic; Nitriles; Pulmonary Disease, Chronic Obstructive | 2001 |